Page last updated: 2024-09-03

3-iodo-alpha-methyltyrosine and Disease Exacerbation

3-iodo-alpha-methyltyrosine has been researched along with Disease Exacerbation in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Debus, J; Eisenhut, M; Haberkorn, U; Henze, M; Hipp, P; Mier, W; Ozdemir-Sahin, N1

Other Studies

1 other study(ies) available for 3-iodo-alpha-methyltyrosine and Disease Exacerbation

ArticleYear
[Comparison of diagnostic accuracy of (18)F-FDG PET, (123)I-IMT- and (99m)Tc-MIBI SPECT: evaluation of tumour progression in irradiated low grade astrocytomas].
    Nuklearmedizin. Nuclear medicine, 2006, Volume: 45, Issue:1

    Topics: Adult; Astrocytoma; Brain Neoplasms; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Methyltyrosines; Middle Aged; Radioisotopes; Reproducibility of Results; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon

2006